CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Elana Thieme(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Alexey V. Danilov(City of Hope)
Cited by 34
Related Papers
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib
|Cancer|2018|86
DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance
|PLoS ONE|2011|83
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis
|Transplantation and Cellular Therapy|2020|60
Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells
|Blood Advances|2019|55
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
|Journal of Hematology & Oncology|2023|52